Abstract
Difloxacin (A-56619) and A-56620, two novel fluoroquinolones, were tested in comparison with ciprofloxacin, cefoxitin, and combined clindamycin and gentamicin in the treatment of experimentally induced intraabdominal abscess associated with Bacteroides fragilis. Difloxacin was found to be as effective as clindamycin-gentamicin. A-56620, despite achieving subtherapeutic levels in serum, was found to be as effective as cefoxitin. Both difloxacin and A-56620 were effective in vivo against experimentally induced intra-abdominal abscess in rats.
MeSH Terms
Abscess/drug therapy
Animals
Anti-Bacterial Agents/metabolism,therapeutic use
Ascitic Fluid/metabolism
Bacteroides Infections/drug therapy
Bacteroides fragilis/drug effects
Ciprofloxacin/analogs & derivatives,metabolism,therapeutic use
Escherichia coli/metabolism
Fluoroquinolones
Half-Life
Male
Microbial Sensitivity Tests
Rats
Rats, Inbred Strains
Chemicals
Anti-Bacterial Agents
Fluoroquinolones
Ciprofloxacin
difloxacin
sarafloxacin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Thadepalli H
Gollapudi S V
Chuah S K
References (14)
14 references, click to expand
-
Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.
Cancer Chemother Rep. 1966 May;50(4):219-44
PMID: 4957125
-
Simplified, accurate method for antibiotic assay of clinical specimens.
Appl Microbiol. 1966 Mar;14(2):170-7
PMID: 4959982
-
Experimental intra-abdominal abscesses in rats: development of an experimental model.
Infect Immun. 1974 Dec;10(6):1250-5
PMID: 4611922
-
Antimicrobial therapy of experimental intraabdominal sepsis.
J Infect Dis. 1975 Sep;132(3):282-6
PMID: 1159331
-
Therapy for experimental intraabdominal sepsis: comparison of four cephalosporins with clindamycin plus gentamicin.
J Infect Dis. 1977 Mar;135 Suppl:S18-22
PMID: 321707
-
In vitro activity of ticarcillin against anaerobic bacteria compared with that of carbenicillin and penicillin.
Antimicrob Agents Chemother. 1977 Feb;11(2):258-61
PMID: 848931
-
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Antimicrob Agents Chemother. 1986 Feb;29(2):201-8
PMID: 3521473
-
In vitro antibacterial activity of norfloxacin (MK-0366).
Antimicrob Agents Chemother. 1982 Apr;21(4):604-7
PMID: 6211139
-
Antimicrobial spectrum of Win 49375.
Antimicrob Agents Chemother. 1984 Jul;26(1):104-7
PMID: 6476813
-
The activity of enoxacin against clinical bacterial isolates in comparison with that of five other agents, and factors affecting that activity.
J Antimicrob Chemother. 1984 Sep;14 Suppl C:7-17
PMID: 6594324
-
In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867).
Antimicrob Agents Chemother. 1984 Nov;26(5):785-6
PMID: 6517561
-
Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitals.
Antimicrob Agents Chemother. 1985 Apr;27(4):657-9
PMID: 3847273
-
In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620.
Antimicrob Agents Chemother. 1985 Oct;28(4):514-20
PMID: 3935046
-
Susceptibility of anaerobic bacteria in vitro to 23 antimicrobial agents.
Chemotherapy. 1980;26(5):344-53
PMID: 6446448